A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

A recent Cleveland Clinic study used AI to create digital twins of patients' metabolisms—and cured 7 in 10 type 2 diabetics.

Inebilizumab-cdon is approved for anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody–positive generalized myasthenia gravis, based on MINT trial results. Inebilizumab gains ...

Curious how elderberry supplements affects blood sugar and the immune system? Learn what current research shows—plus safety ...

Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still ...